June 26, 2004
Oregon-Bioscience.com is a resource of the Oregon Bioscience Association.

 Opinion Poll

Is availability of experienced managers in Oregon constraining your company's growth?

  Yes   No

Please tell us what you think:
 

BioFact:
(1976) National Institutes of Health issues guidelines for DNA splicing.

 
ORCA Meeting, July 7...Sign up now!

UW BioArray Center: Microarray Data Analysis Workshop, July 13 - 14, Seattle

WBBA Summer Social, August 12 - Register Today!


Program for Appropriate Technology in Health

Commercialization Officer I or II, Malaria Vaccine Initiative (MVI)

Title: Commercialization Officer I or II, Malaria Vaccine Initiative (MVI)

Location: Seattle, Washington

(5030) Commercialization Officer I or (5040) Commercialization Officer II.

Starting Annual Salary: $65,000 – $90,000 DOE plus competitive benefits.

Overview:

The Malaria Vaccine Initiative was launched in 1999 to accelerate the development of malaria vaccines and ensure their availability and accessibility in the developing world. To learn more about this important initiative, visit http://www.malariavaccine.org. The program today includes a vibrant portfolio of vaccine development partnerships and supporting agreements. MVI works with partners and thus does not conduct the research and development activities itself.

Duties and Responsibilities:

MVI is seeking a responsible, professional individual with a commercial background for this position. The primary role of the incumbent will be to support the agreements process with MVI’s partners and the commercialization goals and activities of MVI.

Duties and Responsibilities:

  • Perform due diligence on potential partners.
  • Participate in agreements and negotiation processes.
  • Provide economic, market, and business analysis to support MVI projects and partnerships.
  • Collect and analyze financial and commercial benchmarks for the vaccine development industry to support MVI decision-making.
  • Monitor ongoing commercialization and contractual issues within the MVI portfolio, including intellectual property.
  • Prepare MVI input to industry working groups and consultations related to commercialization, intellectual property, and financing in the public health, vaccine and infectious and neglected disease fields.
  • Serve as a working liaison to, and manage daily activities of, outsourced commercialization projects.
  • Contribute to the development of a long-term strategy, goals and activities for the commercialization of a malaria vaccine.
  • Participate in PATH’s Commercialization and Corporate Partnerships team’s cross-functional initiatives.
  • Other duties as assigned.

Qualifications:

  • MBA or Science degree with business development and/or technology commercialization experience.
  • Minimum 3-4 years experience in agreement negotiation, intellectual property management and/or commercialization strategy development; background in biotechnology or pharmaceutical industry required; experience in public health or vaccine industry is desirable.
  • Demonstrated ability to work independently and as part of a team.
  • Demonstrated ability to analyze technology and commercialization scenarios and develop options.
  • Ability to interact with leaders in industry, international organizations, government organizations, and academia.
  • Domestic and international travel is required.

To Apply:

To be considered for this position, please visit our website, http://www.path.org, Job Opportunities.

All posted positions are full time unless otherwise noted.

PATH is dedicated to diversity in staff and is an equal opportunity employer.


Program for Appropriate Technology in Health
Reference Job Code: 1483

Program for Appropriate Technology in Health is an Equal Opportunity Employer

Submitted: 04/22/2004



Print Page

Advanced Technology Construction

Copyright 1996-2004 Info.Resource, Inc., Seattle, WA, USA. 800.709.8907. All rights reserved.
Privacy Policy . Advisory Board . Terms of Use . Advertising

Oregon-Bioscience.com is published by Info.Resource in collaboration with the Oregon Bioscience Association.